CME Group has filed a lawsuit against the U.S. Commodity Futures Trading Commission (CFTC), challenging the regulator's approval of crypto perpetual futures. The exchange argues these products should be classified as swaps under the Dodd-Frank Act, not futures, and that the CFTC bypassed congressional procedures.
CFTC Greenlights Perpetuals, Triggering Legal Battle
According to Bloomberg, CME's complaint targets CFTC Chairman Michael Selig and the agency for reclassifying perpetual-style products. The exchange claims the CFTC historically treated perps as swaps but changed course when approving Kalshi's Bitcoin perpetual (BTCPERP) on May 29, along with other platforms like Coinbase. CME CEO Terrence Duffy told CNBC the company planned to sue, arguing perps inherently fall under swap definitions and should not be treated as standard futures.
Kalshi's BTCPERP generated over $5.5 billion in trading volume within weeks, and the platform later launched perps tied to Ethereum, XRP, and Hyperliquid. Coinbase also secured a regulated route through its Deribit acquisition. The CFTC stated during approval that perp structures may not suit all asset classes and that each product would be reviewed individually.
CME: Perpetuals Are Swaps, Regulator Skipped Rulemaking
In its filing, CME alleges the CFTC deviated from its own precedent—citing the agency's enforcement case against Binance where perps were deemed swaps—and bypassed formal rulemaking. The exchange argues Chairman Selig effectively overrode statutory definitions set by Congress. Additionally, CME raised intellectual property concerns, with Duffy noting that the exchange holds exclusive agreements with benchmark providers and that related products should flow through CME regardless of structure.
Legal Experts: CFTC Has Discretion, Case Not Clear-Cut
A CFTC spokesperson responded that CME chose litigation over competition, framing the suit as resistance to the Trump administration's pro-innovation regulatory approach. StarkWare General Counsel Katherine Kirkpatrick analyzed the dispute on X (June 18). She noted that enforcement positions don't create binding precedent, and federal law does not require the CFTC to spend 45 days or maintain a quorum before acting; the chair may have independent authority to approve products. She added that CME would need to demonstrate actual competitive injury, given offshore perpetual venues already compete with CME.
“Perps are still new(ish), which means they weren't intended to be addressed by Congress when Dodd-Frank was passed. The CFTC has discretion to categorize novel products, and its choice of future vs swap here is reasonable,” Kirkpatrick said.
The lawsuit underscores a key regulatory tension in U.S. crypto derivatives: perpetuals are increasingly mainstream, but their legal classification remains murky. The outcome could force courts or regulators to provide clearer boundaries.